Sleep is an essential human function but its regulation is poorly understood. Identifying genetic variants associated with quality, quantity and timing of sleep will provide biological insights into the regulation of sleep and potential links with disease. Using accelerometer data from 85,670 individuals in the UK Biobank, we performed a genome-wide association study of 8 accelerometer-derived sleep traits. We identified 47 genetic associations across the sleep traits (P<5x10 -8
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INTRODUCTION
Sleep is an essential human function, but many aspects of its regulation remain poorly understood. Adequate sleep is important for health and wellbeing, and variation in sleep quality, quantity and timing are strongly associated with several human diseases and psychiatric disorders [1] [2] [3] [4] [5] . Identifying genetic variants influencing sleep traits will provide new insights into the molecular regulation of sleep in humans and help clarify the genetic contribution to causal links with disease.
Previous large-scale genetic studies have used self-report estimates of sleep to identify genetic variants associated with sleep traits. For example, using questionnaire data from 47,180 individuals, the CHARGE consortium identified the first common genetic variant, near PAX8, robustly associated with sleep duration 6 . Subsequent studies using up to 128,286 individuals in the first phase of the UK Biobank identified two additional sleep duration loci 7, 8 and a parallel analysis of the full UK Biobank release of 446,118 individuals identified a total of 78 associated loci (Dashti et al., BioRxiv, 2018) . Genetic associations have also been identified for other self-reported traits including chronotype [8] [9] [10] , insomnia, and daytime sleepiness 7, 11, 12 (Jansen et al.
BioRxiv, 2018, https://doi.org/10.1101/214973).
Although the reported associations revealed potentially relevant pathways related to mechanisms underlying sleep regulation, self-report measures are typically based on a limited number of questions and subject to bias related to an individual's perception and recall of sleeping patterns. These measures can often reflect well-being rather than specific aspects of sleep. These limitations may reduce the biological relevance of findings and provide inaccurate insights into links with disease. Polysomnography (PSG) is regarded as the "gold standard" method of quantifying nocturnal sleep traits, but it is impractical to perform in large cohorts. Additionally, PSG is burdensome for the participant making it unsuitable for measuring sleep over multiple nights and capturing inter-daily variability. Research-grade activity monitors (accelerometers), also known as actigraphy devices, provide cost-effective estimates of sleep behaviours using validated algorithms 13, 14 . However, accelerometer-based studies have often involved much smaller sample sizes than those required for genome-wide association studies (GWAS) and have generally not focussed on night-time activity 15, 16 . The UK Biobank study is a unique resource collecting vast amounts of clinical, biomarker, and questionnaire data on 500,000 UK residents. Of these, 103,000 participants wore activity monitors continuously for up to 7 days. This study provides an unprecedented opportunity to derive accelerometer-based estimates of sleep quality, quantity and timing and to use these data to study the genetics of sleep traits. We have previously developed a method, validated against PSG using an independent dataset, to extract a range of sleep estimates from the UK Biobank accelerometer data 17 
RESULTS

Measures of sleep quality and quantity are not correlated with sleep timing
Summary statistics for, and correlations between, the eight accelerometer-derived phenotypes are shown in Supplementary Tables 1 and 2 . We observed little correlation between measures of sleep timing and duration (L5 timing rs = -0.02; sleepmidpoint rs = -0.04) and sleep quality estimates (L5 timing rs < 0.04; sleep-midpoint rs < 0.12). These negligible or limited correlations between timing and duration are consistent with data from self-report measures (rs = 0.005). We also observed limited correlation between sleep duration and sleep quality as represented by the number of nocturnal sleep episodes (rs = 0.14) but observed a modest correlation with sleep efficiency (rs = 0.57). We observed modest correlation between self-report sleep duration and accelerometer-derived sleep duration (rs = 0.19) and between self-report chronotype ('morningness') and L5 timing (rs = 0.29) in the same individuals.
Accelerometer-derived estimates of sleep patterns are heritable
We used BOLT-REML to estimate SNP-based heritability (hSNP ) associated with number of nocturnal sleep episodes, 11 (7) associated with sleep duration, 6 (4) associated with L5 timing, 5 (2) associated with sleep efficiency, 2 (1) associated with diurnal inactivity, 1 (0) associated with midpoint-sleep, and 1 (1) associated with M10 timing.
Of these 47 associations, 31 (14) were not previously reported in studies based on self-report measures ( Table 2) .
Replication of 47 genetic associations in 5,819 individuals
We attempted to replicate the 47 associations in up to 5,819 adults from the Whitehall ). We observed similar effect sizes in a subset of 72,510 unrelated
Europeans from the UK Biobank when removing individuals on depression medication and adjusting for BMI and lifestyle factors. To confirm that associations were not influenced by age related differences in sleep, we confirmed that there was also no difference in effect sizes between the youngest and oldest 50% of individuals (above and below the age of 63.7 years) (Supplementary Table 6 ).
Variants associated with sleep quality include known restless legs syndrome, sleep duration, and cognitive decline associated variants
Of the 5 variants associated with sleep efficiency, one is the PAX8 sleep duration signal and one the restless legs syndrome associated signal (MEIS1). Of the 20 loci associated with number of nocturnal sleep episodes, one is represented by the APOE variant (rs429358) that is strongly associated with risk for late-onset Alzheimer's disease and cognitive decline before disease diagnosis 18 . This variant is a proxy for the APOE ε4 risk allele and shows that the ε4 allele is associated with a reduced number of nocturnal sleep episodes (-0.13 sleep episodes; 95% CI: -0.16, -0.11; -8 ). This finding strengthened by additional analyses of the ε2, ε3 and ε4 APOE Alzheimer's disease risk alleles, with an overall reduction in the number of nocturnal sleep episodes observed with higher risk haplotypes (F(5, 72578)=5.36, P=0.001) (Supplementary Table 7 ). This finding is inconsistent with the observational association between cognitive decline in older age and poorer sleep quality [19] [20] [21] [22] . We also noted that the APOE ε4 risk allele was nominally associated (P<0.05) with sleep timing (L5, -1.8 minutes per allele, P=4x10 ). Apart from the APOE variant, there were minimal differences in effect sizes in a range of sensitivity analyses, including removing individuals on sleep or depression medication, adjustments for BMI and lifestyle factors, and splitting the cohort by median age (Supplementary Table 6 and
P=4x10
Supplementary Methods).
Six association signals identified for accelerometer-derived measures of sleep timing
We identified 6 loci associated with L5 timing, of which 3 have not previously been associated with self-report chronotype but have been associated with restless legs Table 6 and Supplementary Methods).
Associated loci are enriched for genes expressed in the cerebellum and the serotonin metabolic process related genes
We used MAGMA 24 to assess tissue enrichment of genes at associated loci across the sleep traits. All traits showed an enrichment of genes in the cerebellum (Supplementary Figures 3 and 4) . As a group, the loci associated with number of nocturnal sleep episodes were enriched for genes involved in the serotonin metabolic process pathway (PBonferroni=0.0003) (Supplementary Table 8 ).
Multiple sleep traits have genetic variants previously associated with restless legs syndrome
We observed most variants to influence either sleep duration, quality, or timing, but not combinations of these sleep characteristics. However, the variant rs113851554 at the MEIS1 locus was associated with sleep duration, quality (sleep efficiency), and timing (L5). In addition, the variant rs9369062 at the BTBD9 locus was associated with both sleep duration and L5 timing. Both variants have previously been reported as associated with restless legs syndrome (Figure 2) . To follow up this observation, we performed Mendelian Randomisation using 20 variants associated with restless legs syndrome in the discovery stage of the most recent and largest genome-wide association study 23 . Our analysis identified variants in loci that were enriched for genes involved in the serotonin processing pathway -the strongest pathway associated with sleep quality.
Serotonin plays a role in sleep cycles 27, 28 . Therefore, it is likely that we are picking up the sleep consequences of restless legs syndrome and provides evidence that restless leg syndrome is one cause of poor sleep. In the UK Biobank, restless legs syndrome was only identified through the Hospital Episodes Statistics (HES) data using the ICD-10 code "G25.8" ("Other specified extrapyramidal and movement disorders"), the parent category of the more specific "G25.81" code ("Restless legs syndrome"). Under the assumption that all individuals reporting "G25.8" had restless legs, we observed 38 individuals within our accelerometer subset. Removing these individuals did not change our conclusions.
Our data provide strong evidence that some accelerometer derived measures of sleep provide more precision than self-report measures, whilst for others there is little gain and questionnaire data is just as effective. For example, of the 11 accelerometerbased sleep duration loci we identified, only one (the PAX8 variant) had been previously identified in self-reported sleep duration GWAS despite these studies having much larger sample sizes. Variants with nominal evidence of association with self-reported sleep duration had weaker effects. This difference may be due to reporting biases and due to the UK Biobank questionnaire asking participants to include nap time in their response. In contrast the accelerometer derived estimates of L5 timing, the least active 5 hours of the day, correlated well with self-report estimates.
These data suggest that the answer to the very simple question "are you a morning or evening person" provides similar power as wearing accelerometers for 7 days and nights. In a parallel GWAS analysis, the PAX8 variant was also associated with selfreport insomnia. In addition, five of the loci were nominally associated (P<0.05) with either self-report sleep-duration or insomnia. At least two of the sleep duration signals have been previously associated with mental health disorders including schizophrenia and migraine 25, 26 .
The Alzheimer's disease risk allele at the APOE locus was seen to have apparently paradoxical associations with sleep related traits. Given the well-established association between the ε4 allele and greater risk of Alzheimer's disease, we would not expect associations between this allele and higher quality of sleep, given previously observed associations of sleeping patterns with cognitive decline and Alzheimer's disease 4 . A similar paradoxical association was also reported recently in a previous study of over 2,300 men aged over 65 with overnight PSG data that showed the total time in stage N3 sleep was higher for individuals carrying two copies of ε4 compared with those carrying one or zero copies Second, the activity monitors were worn up to 10 years from when baseline data was collected. Despite this, the correlation between self-report and activity measures of sleep duration was consistent with previous studies, and the correlation did not differ based on time between baseline (self-report time) and accelerometer wear when splitting by time-difference deciles (r = -0.03, P = 0.94). Finally, the UK Biobank was not a representative cohort of the UK population, as participants had a higher socioeconomic status overall and were healthier, on average, given the prevalence of diseases amongst the participants 33, 34 . This was particularly true of the participants who took part in the activity monitor study.
In conclusion, we have performed the first large-scale GWAS of objective sleep measures. We demonstrate that self-report measures are good proxies for objective sleep measures, but identify additional loci not identified by previous self-report GWAS studies.
METHODS
UK Biobank participants
The study population was drawn from the UK Biobank study -a longitudinal population-based study of individuals living in the UK 34 . Analyses were based on individuals estimated to be of European ancestry. European ancestry was defined through the projection of UK Biobank individuals into the principal component space of the 1000 Genomes Project samples 35 and subsequent clustering based on a Kmeans approach, centering on the means of the first 4 principal components.
Genetic Data
Imputed genetic data was downloaded from the UK Biobank ( 
Activity-monitor Devices
A triaxial accelerometer device (Axivity AX3) was worn between 2.8 and 9.7 years after study baseline by 103,711 individuals from the UK Biobank for a continuous period of up to 7 days. Details of data collection and processing have been previously 
Accelerometer data processing and sleep measure derivations
We derived 8 measures of sleep quality, quantity and timing. All measures were derived by processing raw accelerometer data (.cwa). We first converted the .cwa files available from the UK Biobank to .wav files using "omconvert" for signal calibration to gravitational acceleration 36, 37 Diurnal inactivity. Diurnal inactivity was estimated by the duration of estimated bouts of inactivity that fell outside of the SPT-window.
Comparison against self-reported sleep measures
We performed analyses of self-reported measures of sleep. Self-reported measures analysed included a) the number of hours spent sleeping over a 24-hour period (including naps); b) insomnia; c) chronotype -where "definitely a 'morning' person", "more a 'morning' than 'evening' person", "more an 'evening' than a 'morning' person", "definitely an 'evening' person" and "do not know", were coded as 2, 1, -1, -2 and 0 respectively, in our continuous variable.
Statistical Analysis
Genome-wide association analyses. We performed all association tests in the UK ; non-missing in all genotype batches, total missingness <1.5% and not in a region of long-range LD 40 ) to build the relatedness model and thus to estimate heritability. For LD structure information, we used the default 1000 Genomes 'LDScore' table provided with the BOLT-REML software.
Gene-set, tissue expression enrichment, and overlap with GWAS-catalog analyses.
Gene-set analyses and tissue expression analyses were performed using MAGMA 24 as implemented in the online Functional Mapping and Annotation of Genome-Wide Association Studies (FUMA) tool 41 . Analysis of differentially expressed genes was based on data from GTEx v6 RNA-seq data 42 . Enrichment analyses of the overlap with associations previously reported through GWAS was also implemented through FUMA. Enrichment P-values for the proportion of overlapping genes present was based on the NIH GWAS catalog 43 . 44 . Combined variant effects on respective traits were subsequently calculated using the 'metan' function in STATA using the betas and standard errors obtained through the primary meta-analysis of the three replication studies.
Replication of findings. Associations reaching
Sensitivity Analysis. To assess whether stratification was responsible for any of the individual variant associations in a subset of the cohort, we performed multiple sensitivity analyses in unrelated European subsets of the UK Biobank using STATA.
The sensitivity analyses carried out were: 1) males only, 2) females only 3) individuals younger than the median age (at start of the activity monitor wear period), 4) individuals older than the median age, 5) adjustment for body mass index (BMI) (UK Biobank data field 21001), 6) adjusting for BMI and lifestyle factors and 7) excluding individuals working shifts, taking medication for sleep or psychiatric disorders, self-reporting a mental health or sleep disorder, or diagnosed with depression, schizophrenia, bipolar disorder, anxiety disorders or mood disorder in the HES data (see Supplementary Methods). The sensitivity analyses were performed by regressing the phenotype against the variant dosage, adjusting for the same covariates as described for the BOLT-LMM GWAS and additionally adjusting for the first 5 principal components to account for population structure. All exclusions and adjustments were made using baseline records (taken at the assessment centre). 
Mendelian Randomisation (MR
